Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis

被引:60
作者
Chen, SR
Akbar, SMF
Tanimoto, K
Ninomiya, T
Iuchi, H
Michitaka, K
Horiike, N
Onji, M
机构
[1] Ehime Univ, Sch Med, Dept Internal Med 3, Shigenobu, Ehime 7910295, Japan
[2] Santou Univ, Coll Med, Univ Hosp 2, Santou, Peoples R China
关键词
CD83; dendritic cells; hepatocellular carcinoma; interdigitating cells; liver cirrhosis; S100; protein;
D O I
10.1016/S0304-3835(99)00312-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mature and activated dendritic cells (CD83-positive DCs) are essential for the recruitment and survival of activated tumor-specific lymphocytes during carcinogenesis, The frequencies of CD83 positive DCs were almost same in peripheral blood from patients with hepatocellular carcinoma (HCC) and cirrhosis of liver (LC), However, the numbers of CD83 positive DCs in liver tissues were significant lower in HCC compared with LC (6.6 +/- 10.9 vs. 33.3 +/- 24 DCs/specimen, P < 0.05). Most importantly, there were no CD83-positive DCs at cancer nodules in HCC. A role of infiltration of activated DCs in liver during hepatocarcinogenesis is shown. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 26 条
  • [1] Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells
    Akbar, SMF
    Abe, M
    Masumoto, T
    Horiike, N
    Onji, M
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 755 - 764
  • [2] Unique features of dendritic cells in IFN-γ transgenic mice:: Relevance to cancer development and therapeutic implications
    Akbar, SMF
    Kajino, K
    Tanimoto, K
    Yamamura, E
    Onji, M
    Hino, O
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) : 294 - 299
  • [3] Akbar SMF, 1996, IMMUNOLOGY, V87, P519
  • [4] AKBAR SMF, 1993, IMMUNOLOGY, V78, P468
  • [5] Akbar SMF, 1999, IMMUNOLOGY, V96, P98
  • [6] Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection
    Akbar, SMF
    Onji, M
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1998, 79 (05) : 279 - 291
  • [7] Akbar SMF, 1997, J HEPATOL, V26, P131
  • [8] HEPATITIS-B VIRUS IMMUNOPATHOLOGY
    CHISARI, FV
    FERRARI, C
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1995, 17 (2-3): : 261 - 281
  • [9] DEMETRIS AJ, 1989, AM J PATHOL, V134, P741
  • [10] Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.3.CO